BioSTL’s Post

Fyi: Update on Neuro360: “Rather than silo research and development within different universities’ academic structures and offices of technology development, Raymundo said Neuro360's goal is to create a regional apparatus to bring research alongtoward maturity, linking academics to entrepreneurs, executives, capital and manufacturers to help build up companies.” Informstion is For the St. Louis Region, Community and Beyond, #EcoNetworkSystem for #Founders, #StartUps, #Entrepreneurs, #Innovators, #SMB’s and Others. Some of the content. Please read all of content for more details, Thanks, #StartLouis. “Raymundo said the federal funding would help advance research "to advance discovery and allow us to commercialize it." Rather than silo research and development within different universities’ academic structures and offices of technology development, Raymundo said Neuro360's goal is to create a regional apparatus to bring research alongtoward maturity, linking academics to entrepreneurs, executives, capital and manufacturers to help build up companies. Neuroscience is one of WashU's strengths – its $616 million #JefferyTFortNeuroscienceResearchBuilding opened in January – and #Neuro360 wants to channel resources for academic research, private-sector innovation and human capital development into a self-propelling industry. Neuro360's plan focuses on four areas, according to its website: neuroscientific technology for devices and imaging; molecular, cellular and systems biology; apps, software and computing; and public health. ——- RePosted by: StartLouis Where: “StartUps” / Founders Start ! “ #StartLouis is For the St. Louis Region, Community and Beyond, #EcoNetworkSystem for #Founders, #StartUps, #Entrepreneurs, #Innovators, #SMB’s and Others. ….. For more information Access via web site (MeetUp) “StartLouis”, Thanks. ….. Ed Schneider, StartLouis V5.0 (ESO). Founder, Principal, Lead Organizer. ….. (R:09022401) —————— —- (O:090524-0936p-(00) -(R:0943p). ___

🧠 This is a reminder to register for the first 𝐋𝐞𝐮𝐯𝐞𝐧 𝐁𝐫𝐚𝐢𝐧 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧 𝐃𝐚𝐲 on November 21. We hope to welcome you, academics or industry reps, to the Rega Institute for a day full of high-level brain innovation: panel discussions with leading experts around topics like 𝑻𝒆𝒄𝒉𝒏𝒐𝒍𝒐𝒈𝒚, 𝑫𝒓𝒖𝒈 𝑫𝒆𝒗𝒆𝒍𝒐𝒑𝒎𝒆𝒏𝒕, 𝒂𝒏𝒅 𝑫𝒊𝒔𝒆𝒂𝒔𝒆 𝒎𝒐𝒅𝒆𝒍𝒔, pitches & info booths by neuro & bio tech companies, and many networking opportunities. 🎤 Speakers include Chris Van Hoof (imec), Wim Van Hecke (Icometrix), Eugeen Vanmechelen (Adx neurosciences), Els Henckaerts (UCB), Tom Cornelissen (reMYND), Bart De Strooper (UKDR/VIB-KU Leuven Center For Brain & Disease Research), Rik Vandenberghe (UZ Leuven, KU Leuven), Koen Van Laere (UZ Leuven, Faculteit Geneeskunde KU Leuven Faculty of Medicine), Myles Mc Laughlin (ExpORL), Lies De Groef (KU Leuven) 🦾 This event aims to bring together key stakeholders from the wider Leuven brain research community (researchers, clinicians, and industry) to explore the importance of innovation, create synergies, and showcase how academia can collaborate with industry. 📣 Registration deadline for sponsored company pitches closes end of this month, so don't miss this opportunity and grab your place (limited to 6, we still have 2 empty spots). Also other packages are available with information booth + digital banner and social media exposure, check out all sponsoring packages here https://lnkd.in/eujDvrdD 💡Discover the LBI ecosystem! The event is open for all neuroscience researchers and clinicians from all levels working in academia and industry. Join 200+ neuroscience professionals, and dive deep into the future of 𝒃𝒓𝒂𝒊𝒏 𝒓𝒆𝒔𝒆𝒂𝒓𝒄𝒉, 𝒉𝒆𝒂𝒍𝒕𝒉 & 𝒊𝒏𝒏𝒐𝒗𝒂𝒕𝒊𝒐𝒏 in Leuven. #LBIDay #neuroscience #innovation #braintech #brainhealth #neurotech #biotech

I presentation not to ever miss, of another exceptional speaker for NeuroCon 24: Dr. Thomas Boraud, a brilliant neuroscientist and medical doctor from France! Dr. Boraud's work on decision-making and action selection in the brain is truly fascinating. His research combines in vivo recordings across species with computational analysis, offering unique insights into disorders like Parkinson's and OCD. As the Head of the Institute of Neurodegenerative Disease in Bordeaux, he's at the forefront of bridging research and clinical practice. What excites me most about Dr. Boraud's participation is how his work exemplifies the interdisciplinary nature of modern neuroscience. From basal ganglia function to computational models of decision-making, his research touches on many of the themes we'll explore at NeuroCon 24. I strongly encourage my network, especially those interested in neuroscience, decision research, or neurological disorders, to join us for this event. Dr. Boraud's insights, along with those of our other outstanding speakers, promise to make NeuroCon 24 an unforgettable experience. Don't miss this opportunity to learn from and interact with leading minds in neuroscience. Register now for NeuroCon 24! Event Details: NeuroCon 24 Online October 24-26, 2024 Starting at 10:00 GMT +3 Register here: www.neurocon.eu Feel free to reach out if you have any questions about the event or Dr. Boraud's session. Let's advance our understanding of the brain together! #NeuroCon24 #Neuroscience #DecisionMaking #ContinuingEducation

I am pleased to announce my participation in the recent Medical Biophysics Student Research Symposium, where I had the privilege of presenting our groundbreaking research endeavors. Here's an overview of our noteworthy contributions: 🔍 Applied advanced ultra-high field MRI techniques, significantly augmenting our ability to uncover novel neurological biomarkers. 📊 Analyzed MRI data utilizing ImageJ and sophisticated statistical tools, yielding profound insights into intricate neurological processes. 🤝 Collaborated closely with esteemed multidisciplinary teams, catalyzing pioneering advancements in ultra-high field MRI for neurological research. 🔬 Employed high-resolution transmission electron microscopy to conduct exhaustive histological analyses of glial cells, thereby enhancing our comprehension of cellular dynamics in neurological contexts. 🎓 Showcased our cutting-edge research findings at the Annual A. C. Burton Day, serving as a distinguished representative of our team's innovative contributions to the field. Gratitude abounds for the opportunity to contribute to such impactful research endeavors. I eagerly anticipate the continuation of our collective journey toward unraveling the complexities of the human brain! 💡🧠 #NeuroScience #Research #MRI #MedicalBiophysics #TeamWork #Innovation Let's persist in pushing the boundaries of knowledge together! 👩🔬🚀

🚀 Get to Know Dr. Hila Ben-Moshe: Rafa’s Moonshot Scientific Director 🚀 In our latest blog post, we interviewed our newest addition to the team, Scientific Director Dr. Hila Ben-Moshe, to get to know her better. Read the full blog below 👇 We are excited to have Hila's experience and innovative thinking in our fight against STXBP1 ✨ Follow our journey on LinkedIn for updates on our research and collaborations. #Neuroscience #STXBP1 #RareDiseases #GeneticResearch #Innovation #Healthcare #RafasMoonshot

🎉 Congratulations to our research partners, .NeuroRestore co-directors G. Courtine and Jocelyne Bloch, for delivering the closing plenary lecture at the #FENS2024 Forum in Vienna, Austria. The duo spoke to the enthusiastic audience at the Federation of European Neuroscience Societies - FENS conference about the therapies they have developed to address the unmet needs of people with spinal cord injury (SCI). The FENS Forum is Europe’s largest #neuroscience congress, covering all areas of the field, from basic to translational research, and highlighting the most up-to-date research discoveries in neuroscience. FENS represents 40 neuroscience societies and more than 20K member scientists, and conference participants gather to listen, learn, and share.   We appreciate FENS for showcasing the latest breakthroughs in neurotechnology and the work that Professor Courtine and Dr. Bloch are doing to develop innovative solutions for those with SCI. ✨   *All ONWARD® Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use.   #EmpoweringMovement #SCI #Neuroscience #FENS2024

Combing local and system brain info to advance brain care: This NIH grant mechanism supports research involving both intra-cranial recordings and neuroimaging, a needed integrated approach to build the needed bedrock for better solutions in clinical neuroscience. Information from both neuroimaging and intra-cranial recordings provides a larger systems neuroscience picture and a finer detailed view about smaller brain regions of interest. One could ask how stimulating one brain area affects other areas with this approach. This could be important to know in creating brain implants to address serious brain disease. Why? Many devastating brain diseases continue to be poorly addressed by current treatments, leading to this inclusion of intra-cranial recordings as an emphasized method here if neuroethic requirements are met. Functional brain regions are organized in networks, so knowing the full effect of stimulating one area includes how that stimulation influences brain activity elsewhere. Science Career Implications: This research program highlights why education and specialty training in science must include team assignments as most areas of science are now team sports. Learning how to work well with others includes planning ahead so effort invested and later credit given are matched across team members. Setting up win-win-win plans before the work starts can help avoid conflicts later.

Dead brains tell no tales: Why living tissue is revolutionizing neuroscience The recent study on RNA editing in living versus post-mortem brain tissue reveals crucial insights for neuroscience and medical research. As technology leaders, we must recognize the profound implications this has for our understanding of brain function and disease mechanisms. The discovery of significant differences in A-to-I RNA editing between living and deceased brain samples highlights the importance of using fresh tissue in neurological research. This finding challenges our previous assumptions and opens new avenues for developing more accurate diagnostic tools and targeted therapies for neurological disorders. For those working in healthcare tech and biotech, this research underscores the need for innovative approaches to obtain and analyze living brain tissue. It also emphasizes the critical role of advanced data analysis techniques in uncovering subtle yet significant biological differences. Moving forward, we must invest in technologies that enable real-time analysis of brain function and support the development of non-invasive methods for studying living brain tissue. This could revolutionize our approach to neurological research and lead to breakthroughs in treating complex brain disorders. #Neuroscience #RNAEditing #BrainResearch #HealthcareTech #Biotech #MedicalInnovation #NeurologicalDisorders

Pioneering ALS research - one gift at a time! Briana Ondatje, a PhD student and Fast Track Awardee for Translational Neuroscience, through the support of the Foundation, is investigating cell communication in the brain & spinal cord and how that communication is dysregulated in patients with ALS. We are so excited about what's in store for her research and the implications her findings could have for ALS patients. Click here to read more about Briana and her study: https://lnkd.in/gh7i9QF5

🚀🧠 Big news for St. Louis. The NEURO360 initiative, led by BioSTL and Washington University in St. Louis, is aiming to transform the region into a global neuroscience powerhouse. The project seeks to boost the local neurotech ecosystem and position St. Louis at the forefront of neuroscience research. From enhancing treatments for Alzheimer’s to advancing mental health solutions, NEURO360 hopes to drive innovation and create new job opportunities across sectors. This initiative builds on decades of progress in the region, with BioSTL having already launched 100 new companies and created around 1,000 jobs. Read more below. 🌟🔬 #NEURO360 #StLouisInnovation #Neuroscience #Neurotech #BioSTL #WashingtonUniversity #ScienceNews #TechHubs #InnovationEcosystem #FutureOfScience